Skip to main content
. 2019 May 3;10:459. doi: 10.3389/fneur.2019.00459

Table 2.

Brain MRI findings in the RMS and SPMS patients at study baseline and at 2 years.

RRMS SPMS p-value
Variable Baseline Follow-up Baseline Follow-up Baseline Follow-up
N 24 23 36 35
Gd+ lesions (N, %) 4/24 (17) 1/23 (4) 2/36 (6) 4/35 (11) 0.248 0.677
Total BP vol. (ml, SD) 1509.5 (109.26) 1482.3 (110.87) 1397.9 (107.11) 1404.7 (107.49) 0.001 0.012
Total WM vol. (ml, SD) 688.6 (51.40) 678.0 (45.09) 648.1 (49.05) 652.9 (53.10) 0.011 0.084
Total GM vol. (ml, SD) 820.7 (67.03) 804.1 (74.16) 749.9 (66.24) 751.7 (67.66) <0.001 0.007
WM lesion vol. (ml, SD) 11.0 (8.35) 10.2 (8.43) 20.2 (12.26) 20.4 (13.29) <0.001 <0.001
Putamen vol. (ml, SD) 4.4 (0.58) 4.4 (0.61) 4.0 (0.63) 4.0 (0.67) 0.020 0.065
Hippocampus vol. (ml, SD) 3.9 (0.48) 3.9 (0.55) 3.5 (0.44) 3.4 (0.48) 0.008 0.006
Thalamus vol. (ml, SD) 7.2 (0.80) 7.3 (0.82) 6.2 (0.95) 6.2 (0.97) <0.001 <0.001
Nucleus caudatus vol. (ml, SD) 2.9 (0.41) 2.8 (0.45) 2.5 (0.40) 2.5 (0.43) <0.001 0.014
Globus pallidus vol. (ml, SD) 1.3 (0.15) 1.2 (0.16) 1.1 (0.14) 1.1 (0.14) 0.003 0.020
Cerebellum WM vol. (ml, SD) 15.7 (2.36) 15.8 (2.25) 11.9 (2.97) 11.6 (2.62) <0.001 <0.001
Cerebellum GM vol. (ml, SD) 55.1 (5.18) 57.1 (5.92) 54.7 (7.21) 54.1 (7.34) 0.769 0.127

The bold values indicate statistically significant p-values.